Kiromic BioPharma Announces Strategic Collaboration With Gemelli Teaching Hospital To Accelerate The Analysis Of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 In Solid Cancers
Kiromic BioPharma, Inc. (NASDAQ:KRBP) (“Kiromic” or the “Company”), a pre-clinical stage biotechnology company using its proprietary DIAMOND® artificial intelligence (AI) platform to improve